Browse > Article
http://dx.doi.org/10.3340/jkns.2009.46.6.558

Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans  

Hong, Seok-Ho (Department of Neurosurgery, Seoul National University College of Medicine)
Wang, Kyu-Chang (Department of Neurosurgery, Seoul National University College of Medicine)
Kim, Seung-Ki (Department of Neurosurgery, Seoul National University College of Medicine)
Cho, Byung-Kyu (Department of Neurosurgery, Seoul National University College of Medicine)
Park, Myoung-Hee (Laboratory Medicine, Seoul National University College of Medicine)
Publication Information
Journal of Korean Neurosurgical Society / v.46, no.6, 2009 , pp. 558-563 More about this Journal
Abstract
Objective : Moyamoya disease (MMD) is an uncommon cerebrovascular disorder, characterized by progressive occlusion at the terminal portion of the internal carotid artery. Incidence of the disease is high in East Asia and familial MMD accounts for about 15% of the disease. Although the pathogenesis is unknown, association of HLA class I or II alleles with MMD has been reported with conflicting results. We investigated whether there is a difference in HLA class II association between familial and non-familial forms of the disease. Methods : A total of 70 Korean children with MMD, including 16 familial cases (10 probands), and 207 healthy controls were studied. Among familial cases, only 10 probands were used for the HLA frequency analysis. High resolution HLA-DRB1 and DQB1 genotyping was performed using polymerase chain reaction (PCR)-sequence specific oligonucleotide hybridization and PCR-single strand conformation polymorphism methods. Results : The phenotype frequencies of HLA-DRB1*1302 (70.0%) and DQB1*0609 (40.0%) were significantly increased in familial MMD compared to both controls [vs. 15.5%, corrected p ($p_c$) = 0.008, odds ratio (OR) = 12.76; vs. 4.3%, $p_c\;=\;0.02$, OR = 14.67] and non-familial MMD patients (vs. 14.8%, $p_c\;=\;0.02$, OR = 13.42; vs. 1.9%, $p_c\;=\;0.02$, OR = 35.33). The frequencies of DRB1 and DQB1 alleles in non-familial MMD patients were not significantly different from those in controls. Conclusion : Our findings suggest that the genetic polymorphism of HLA class II genes or other closely linked disease relevant gene(s) could be a genetic predisposing factor for familial MMD.
Keywords
Moyamoya disease; Familial; HLA-DR; HLA-DQ;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 7
연도 인용수 순위
1 Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K : Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27 : 1750-1754, 1996   DOI   ScienceOn
2 Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K : Human leukocyte antigen in patients with moyamoya disease. Stroke 26 : 415-417, 1995   DOI   ScienceOn
3 Goto Y, Yonekawa Y : Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32 : 883-886, 1992   DOI
4 Houkin K, Yoshimoto T, Abe H, Nagashima K, Nagashima M, Takeda M, et al. : Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. Neurosurg Focus 5 : 1-5, 1998
5 Inoue TK, Ikezaki K, Sasazuki T, Ono T, Kamikawaji N, Matsushima T, et al. : DNA typing of HLA in the patients with moyamoya disease. Jpn J Hum Genet 42 : 507-515, 1997   DOI
6 Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. : Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70 : 2357-2363, 2008   DOI   ScienceOn
7 Shi Y, Patel S, Niculescu R, Chung W, Desrochers P, Zalewski A : Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol 19 : 1150-1155, 1999   DOI   ScienceOn
8 Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. : Epidemiological features of moyamoya disease in Japan : findings from a nationwide survey. Clin Neurol Neurosurg 99 : S1-S5, 1997   DOI   ScienceOn
9 Kitahara T, Okumura K, Semba A, Yamaura A, Makino H : Genetic and immunologic analysis on moya-moya. J Neurol Neurosurg Psychiatry 45 : 1048-1052, 1982   DOI
10 Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta KI, et al. : Inheritance pattern of familial moyamoya disease : autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 77 : 1025-1029, 2006   DOI   ScienceOn
11 Hashitaka H, Liu W, Mineharu Y, Inoue K, Takenaka K, Ikeda H, et al. : [Current knowledge on the genetic factors involved in moyamoya disease.] Brain Nerve 60 : 1261-1269, 2008
12 Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T : Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64 : 533-537, 1999   DOI   ScienceOn
13 Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M : Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15 : 179-182, 2000   DOI   ScienceOn
14 Bannai M, Tokunaga K, Lin L, Kuwata S, Mazda T, Amaki I, et al. : Discrimination of human HLA-DRB1 alleles by PCR-SSCP (singlestrand conformation polymorphism) method. Eur J Immunogenet 21 : 1-9, 1994   DOI   ScienceOn
15 Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y : Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke 35 : 2837-2842, 2004   DOI   ScienceOn
16 Fukui M, Kono S, Sueishi K, Ikezaki K : Moyamoya disease. Neuropathology 20 : S61-S64, 2000   DOI   ScienceOn
17 Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. : Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31 : 930-935, 2000   DOI   ScienceOn
18 Song EY, Park MH, Kang SJ, Park HJ, Kim BC, Tokunaga K, et al. : HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 59 : 475-486, 2002   DOI   ScienceOn
19 McManus DP, Ross AG, Williams GM, Sleigh AC, Wiest P, Erlich H, et al. : HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int J Parasitol 31 : 674-680, 2001   DOI   ScienceOn
20 Park MH, Whang DH, Kang SJ : High resolution HLA-DQB1 typing by combination of PCR-RFLP and PCR-SSCP. Hum Immunol 60 : 901-907, 1999   DOI   ScienceOn
21 Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC : Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 58 : 1074-1080, 2006   DOI   ScienceOn
22 Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, et al. : Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease. Stroke 34 : 2835-2841, 2003   DOI   ScienceOn
23 Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M : Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clinical Neurol Neurosurg 99: S234-S237, 1997
24 Kuroda S, Houkin K : Moyamoya disease : current concepts and future perspectives. Lancet Neurol 7 : 1056-1066, 2008   DOI   ScienceOn
25 Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T : Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol [Epub ahead of print], 2009   DOI   ScienceOn
26 Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M, et al. : A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49 : 278-281, 2004   DOI   ScienceOn
27 Fukui M : Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of willis (‘moyamoya’ diseases). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 : S238-S240, 1997
28 Saito S, Ota S, Yamada E, Inoko H, Ota M : Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56 : 522-529, 2000   DOI   ScienceOn
29 Yamauchi T, Houkin K, Tada M, Abe H : Familial occurrence of moyamoya disease. Clin Neurol Neurosurg 99 : S162-S167, 1997
30 Han H, Pyo CW, Yoo DS, Huh PW, Cho KS, Kim DS : Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 18 : 876-880, 2003   DOI   ScienceOn
31 Park YJ, Park H, Park MH : TNF-$\alpha$ promoter polymorphisms and extended HLA and TNF-$\alpha$ haplotypes in Koreans based on 100 families. Tissue Antigens 63 : 75-79, 2004   DOI   ScienceOn
32 Soriano SG, Cowan DB, Proctor MR, Scott RM : Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 50 : 544-549, 2002   DOI   ScienceOn